Brazil's health regulator Anvisa said it has scheduled a meeting on Sunday to decide on the emergency use of COVID-19 vaccines developed by China's Sinovac Biotech and by AstraZeneca PLC jointly with Oxford University.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3